Impact of Predialytic Oral Protein on Nutritional Status and Quality of Life in HD Patients

NCT05952570 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2024-07-09

No results posted yet for this study

Summary

The aim of this work is to study the effects of oral protein-based supplements on nutritional status in hemodialysis patients

Conditions

  • Hemodialysis Complication

Interventions

DIETARY_SUPPLEMENT

oral protein nutritional supplement (Fresubin protein powder)

50 patients will receive oral protein nutritional supplement (Fresubin protein powder 25mg/5scoops per hemodialysis session) 1 hour before the start of the session (predialytic) for 3 months

OTHER

routine nutrition regimen

50 patients will receive a routine nutrition regimen for 3 months. (control group)

Sponsors & Collaborators

  • Alexandria University

    lead OTHER

Principal Investigators

  • Mohamed Mamdouh Elsayed, MD · lecturer

  • Amr El Kazaz, MBBCh · resident

  • Eman E EL Gohary, MD · Professor

  • Mohamed M Abdel Kader, MD · Professor

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-08-01
Primary Completion
2024-06-15
Completion
2024-07-01

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05952570 on ClinicalTrials.gov